BDBM190359 US9670202, Example01.04 4-(2-{[2-ethoxy-4-(morpholin-4-ylcarbonyl)phenyl]amino}[1,2,4]triazolo-[1,5-a]pyridin-6-yl)-N-(4-fluorobenzyl)piperazine-1-carboxamide::US9670202, Example02.01 1-(2-{[2-ethoxy-4-(morpholin-4-ylcarbonyl)phenyl]amino}[1,2,4]triazolo-[1,5-a]pyridin-6-yl)-N-(4-fluorobenzyl)piperidine-4-carboxamide

SMILES CCOc1cc(ccc1Nc1nc2ccc(cn2n1)N1CCN(CC1)C(=O)NCc1ccc(F)cc1)C(=O)N1CCOCC1

InChI Key InChIKey=WDBKEVXQSUERKB-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 190359   

TargetDual specificity protein kinase TTK(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM190359(US9670202, Example02.01 1-(2-{[2-ethoxy-4-(morphol...)
Affinity DataIC50: 2.60E+3nMpH: 7.7Assay Description:For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent

TargetDual specificity protein kinase TTK(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM190359(US9670202, Example02.01 1-(2-{[2-ethoxy-4-(morphol...)
Affinity DataIC50: 3.22E+4nMpH: 7.7Assay Description:For the assay 50 nl of a 100-fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2018
Entry Details
Go to US Patent